Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against HBV
Lamrayat et al., Antiviral Research, 2023 / Team HepVir
in collaboration with Team of Bernard Verrier, IBCP, Lyon
https://www.sciencedirect.com/science/article/abs/pii/S0166354222002522?via%3Dihub